ZBIO currently public float of 22.91M.The average trading volume of ZBIO on September 27, 2024 was 335.02K shares.
ZBIO) stock’s latest price update
Zenas Biopharma Inc. (NASDAQ: ZBIO)’s stock price has gone decline by -6.13 in comparison to its previous close of 18.42, however, the company has experienced a -1.31% decrease in its stock price over the last five trading days. 247wallst.com reported 2024-09-22 that 24/7 Wall St. Insights Initial public offerings at three biotechs last week tempted insiders to make huge purchases of shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ZBIO’s Market Performance
The simple moving average for the past 20 days is -5.35% for ZBIO’s stock, with a -5.35% simple moving average for the past 200 days.
ZBIO Trading at -5.35% from the 50-Day Moving Average
After a stumble in the market that brought ZBIO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -15.66% of loss for the given period.
During the last 5 trading sessions, ZBIO fell by -1.31%, in comparison to the 20-day moving average. In addition, Zenas Biopharma Inc. saw -4.74% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ZBIO starting from MOULDER LEON O JR, who purchase 10,000 shares at the price of $17.91 back on Sep 18 ’24. After this action, MOULDER LEON O JR now owns 1,662,039 shares of Zenas Biopharma Inc., valued at $179,100 using the latest closing price.
MOULDER LEON O JR, the Chief Executive Officer of Zenas Biopharma Inc., purchase 5,000 shares at $18.45 during a trade that took place back on Sep 20 ’24, which means that MOULDER LEON O JR is holding 1,672,039 shares at $92,270 based on the most recent closing price.
Stock Fundamentals for ZBIO
The liquidity ratio also appears to be rather interesting for investors as it stands at 4.82.
Conclusion
In a nutshell, Zenas Biopharma Inc. (ZBIO) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
